Varian Medical Systems
-
The next breakthrough in cancer treatment
An investigational treatment approach that may help us move beyond the limitations of normal tissue tolerance to radiation is clinically feasible for the first time. If successful, it could lead to profound changes in cancer care.
-
Epic Sciences raises $52M Series E round to advance liquid biopsy diagnostics
The San Diego-based firm plans to integrate its “No Cell Left Behind” platform with electronic medical records and big data analytics.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.